CIK 0001680367 · Non-accelerated filer<br>Smaller reporting company
Shattuck Labs, Inc.
Sign in to watch- Ticker
- STTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812575858
- Phone
- 512-900-4690
- Business address
- 500 W. 5TH STREET, AUSTIN, TX, 78701
- Former names
- Shattuck Labs, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-12 | Shukla Abhinav A. Chief Technical Officer | Sale 10b5-1 | −2,032 | $7.01 | $14K | 81,258 |
| 2026-05-12 | Shukla Abhinav A. Chief Technical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,032 | 50,168 | ||
| 2026-05-12 | Pandite Arundathy N. Chief Medical Officer | Sale 10b5-1 | −30,000 | $6.61 | $198K | 166,219 |
| 2026-05-12 | Schreiber Taylor Chief Executive Officer | Grant or award | +25,610 | $1.08 | $28K | 122,222 |
| 2026-05-12 | Schreiber Taylor Chief Executive Officer | Option exercise · Warrants (Right to Buy) | −25,610 | 0 | ||
| 2026-05-10 | Stout Stephen See Remarks | Shares withheld for taxes | −968 | $6.85 | $7K | 80,561 |
| 2026-01-25 | Pandite Arundathy N. Chief Medical Officer | Shares withheld for taxes | −3,195 | $4.15 | $13K | 196,219 |
| 2026-01-25 | Stout Stephen See Remarks | Shares withheld for taxes | −593 | $4.15 | $2K | 81,529 |
| 2026-01-25 | DeYoung Casi Chief Business Officer | Shares withheld for taxes | −2,286 | $4.15 | $9K | 73,480 |
| 2026-01-25 | Neill Andrew R Chief Financial Officer | Shares withheld for taxes | −2,589 | $4.15 | $11K | 228,224 |
| 2026-01-10 | Stout Stephen See Remarks | Shares withheld for taxes | −4,153 | $4.75 | $20K | 82,122 |
| 2026-01-10 | Stout Stephen See Remarks | Grant or award · Stock Option (Right to Buy) | +351,400 | 351,400 | ||
| 2026-01-10 | DeYoung Casi Chief Business Officer | Shares withheld for taxes | −5,699 | $4.75 | $27K | 75,766 |
| 2026-01-10 | DeYoung Casi Chief Business Officer | Grant or award · Common Stock | +381,600 | 381,600 | ||
| 2026-01-10 | Shukla Abhinav A. Chief Technical Officer | Grant or award · Common Stock | +315,500 | 315,500 | ||
| 2026-01-10 | Pandite Arundathy N. Chief Medical Officer | Shares withheld for taxes | −6,851 | $4.75 | $33K | 199,414 |
| 2026-01-10 | Pandite Arundathy N. Chief Medical Officer | Grant or award · Common Stock | +487,800 | 487,800 | ||
| 2026-01-10 | Neill Andrew R Chief Financial Officer | Shares withheld for taxes | −6,660 | $4.75 | $32K | 230,813 |
| 2026-01-10 | Neill Andrew R Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +549,800 | 549,800 | ||
| 2026-01-10 | Schreiber Taylor Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,548,300 | 1,548,300 |
Page 3 of 7 · 140 trades